For patients with type 2 diabetes, the benefits of semaglutide for glycemic and weight control have been shown, but less is known about kidney outcomes in those who also have chronic kidney disease.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: [ Ссылка ]
#endocrinology #nephrology #clinicalmedicine #clinicaltrials #nejm
